Breathe Better  ·  Hear Better  ·  Live Better
Physician Action Toolkit

Two Issues. One Comment Window.

The CY2027 proposed rule hits ENT and allergy differently — with different provisions, different stakes, and different asks. Find your section below. Both deadlines close September 14, 2026.

Choose your specialty. Generate your letter. Submit.
🍑  Georgia Physicians: Support MAG Resolution 324C.26 on Allergen Immunotherapy — Testimonies needed now.  Take action →
⚠️  Public Comment Deadline: September 14, 2026 — loading…
Key Dates
Jul 14, 2026 CMS Proposed Rule Released
Sep 14, 2026 Public Comment Deadline
Fall 2026 CMS Reviews Comments
Jan 1, 2027 Proposed Implementation
🦻
I Practice ENT
Oppose the Modifier 25 same-day cut — an estimated −9% in specialty RVUs, and it has been stopped before
Go to ENT Section →
🌿
I Practice Allergy
Comment on CPT 95165 — CMS is soliciting input on the dose definition and dose limits it has avoided for years
Go to Allergy Section →
🦻 For ENT Physicians

The Modifier 25 Same-Day Cut

CMS proposes to pay only 50 cents on the dollar for any service billed on the same day as a procedure — the exact workflow that defines ENT practice. Otolaryngology faces one of the two largest specialty RVU cuts in the entire proposed rule. CMS withdrew nearly identical cuts in 2019 after physicians commented. The window is open again.

−9%
Estimated ENT specialty RVU reduction in CY2027 — one of the two largest cuts of any specialty
Conversion factor decline applied on top
50%
Proposed payment rate for the secondary service when a procedure and E&M visit occur on the same day
Currently paid at 100%
Sep 14
Public comment deadline — the only window to influence the final rule before November
Final rule expected ~November 1 · Effective January 1, 2027
✅

This Has Been Stopped Before — And It Can Be Again

CMS proposed nearly identical Modifier 25 cuts in the CY2019 Physician Fee Schedule. After a strong response from specialty societies during the public comment period, CMS withdrew the proposal entirely. This year's comment deadline is September 14 — and the same opportunity exists right now.

🔬 How the Proposed Cut Works

  • When you bill an office E&M on the same day as a procedure with a 0-, 10-, or 90-day global period, only the highest-value service is paid at 100%
  • Every additional service billed that day — including the E&M — is paid at 50 cents on the dollar
  • CMS argues this avoids "duplicate payment" — but the E&M must already meet the "significant and separately identifiable" standard to be billed at all
  • CMS is also soliciting comment on extending the policy to inpatient and other E&M families
  • Conversion factor also declines to $32.8409: −1.19% for APM participants, −1.68% for all others — on top of the RVU hit

👂 Why ENT Is Hit Hardest

  • The cut targets a workflow — evaluate, diagnose, treat in one visit — that is the standard of care in ENT
  • Procedures commonly affected: nasal endoscopy (31231), flexible laryngoscopy (31575), cerumen removal (69210), sinus debridement, biopsy, epistaxis control, in-office tympanostomy
  • Every one carries a global period, making the same-day E&M billable with Modifier 25 — and now exposed to the cut
  • CMS explicitly names otolaryngology and dermatology as the two specialties facing the largest negative impact
  • Commercial payers have historically followed CMS edits — the full exposure could be significantly larger than the Medicare figures alone
SpecialtyEst. CY2027 RVU ImpactPrimary Driver
Otolaryngology (ENT)Approx. −9%Same-day E&M + in-office procedure
Allergy & ImmunologyApprox. −1% to −2%Conversion factor only — allergy codes generally lack global periods
DermatologyApprox. −9%Same-day E&M + lesion procedure
Orthopedic SurgeryApprox. −7%Same-day E&M + injection or casting
Clinical PsychologyApprox. +11%Redistribution of RVUs
Clinical Social WorkApprox. +12%Redistribution of RVUs
Source: CY2027 PFS proposed rule regulatory impact analysis, Table D-B5. RVU impacts shown before conversion factor reduction.
Take Action — Comment Period Closes September 14
✍ Write My Congressional Letter 🏛 Generate My CMS Comment Submit on Regulations.gov ↗
or
🌿 For Allergy Physicians

CPT 95165: An Unusual Opening

There is something unusual in this year's proposed rule: CMS is asking a question it has declined to ask for years. In CMS-1848-P, CMS is soliciting public comment on two issues that sit at the center of how every allergy practice operates. ACAAI's Advocacy Council will file a formal position — but that position lands very differently when CMS reads it alongside letters from a hundred practicing allergists.

CMS Is Specifically Soliciting Comment On:
① The 95165 "Dose" Definition
Current Medicare Definition
A 1cc aliquot — regardless of the volume actually prepared for or administered to the patient
↕
ACAAI Position
Rescind the 1cc definition. Adopt the AMA CPT definition — which ties payment to the dose actually prepared and administered
② The 30-Dose Medically Unlikely Edit
Current MUE
30 doses per claim — an administrative per-claim cap with no clinical basis, applied regardless of where the patient is in therapy
↕
ACAAI Position
Replace with clinically grounded annual limits: 150 doses in Year 1 (build-up included) and 120 doses in maintenance
✉️ Why Individual Physician Letters Matter Here

ACAAI's Advocacy Council will submit both positions as a formal society comment. But CMS weighs that differently when the same positions appear in letters from practicing allergists across the country. A brief, personal letter from your practice — describing how the 1cc definition or the 30-dose MUE affects real patients — signals that these are operational realities, not academic concerns. The window closes September 14, 2026.

Other CY2027 Provisions Allergy Practices Should Know
Conversion factor drops to $32.8409 (−1.68%; −1.19% for APM participants) — applies to every dose of 95165 billed to Medicare
RPM/RTM: CMS proposes to bar third-party vendors from furnishing remote monitoring — a direct concern for practices that outsource these programs
Practice expense: indirect cost index phased out over two years; new 5% annual cap limits year-to-year PE swings
Take Action — Comment Period Closes September 14
✍ Write My Congressional Letter 🏛 Generate My CMS Comment Submit on Regulations.gov ↗
3

Engage Your Network

Share with colleagues, professional organizations, and on social media. The more physician voices speaking up, the harder it is for CMS to ignore.

#ProtectPatientAccess #SaveSpecialtyCare #ENTAdvocacy #SENTACares
Share on LinkedIn
4

Share a Patient Story

Real clinical examples are the most powerful advocacy tool we have. If you have a case that illustrates what these cuts would mean in practice, we want to hear it.

⏱ Just a few minutes of your time
📩 Share Your Story
📋 Official CMS Docket — File Code CMS-1848-P
🏛 Submit on Regulations.gov ↗ 📂 View Full Docket ↗ 📄 Federal Register Rule ↗
Comment period closes September 14, 2026. Use the form below to generate your personalized letter or CMS comment, then copy and paste it to submit.
✍️

Write & Send Your Letter

Select your specialty, fill in your information, choose your target, and we'll generate a personalized letter. Edit it freely — then send directly to Congress or submit to the official CMS docket.
Specialty:
Your Representatives
Your Letter — Review & Edit Before Sending ✏️ Click anywhere in the letter to edit
SENTA physician with patient

Your Story Could Shape Policy

Compelling advocacy starts with real experiences. If you have a patient case or practice example that illustrates what these proposed payment changes would actually mean — on access, timing, and outcomes — your story may help inform our outreach to CMS, legislators, and coalition partners.

Send Your Story to SENTA